Redmile Group’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.74M Hold
2025
Q1
$2.63M Hold
2024
Q4
$1.97M Hold
2024
Q3
$3.44M Hold
2024
Q2
$3.73M Hold
2024
Q1
$6.91M Hold
2023
Q4
$3.28M Hold
2023
Q3
$3.09M Hold
2023
Q2
$4.21M Hold
2023
Q1
$3.44M Sell
2022
Q4
$9.86M Hold
2022
Q3
$12.9M Hold
2022
Q2
$8.05M Hold
2022
Q1
$12.4M Hold
2021
Q4
$15.5M Hold
2021
Q3
$16.7M Hold
2021
Q2
$30.6M Sell
2021
Q1
$42.9M Buy